Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Overcoming Real-World Barriers to TED Treatment
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Genesis & Tell-All-Tribune: Where the Future of Aesthetics and Regenerative Medicine Begins
August 21, 2026
Miami, Florida
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Steven Yeh, MD, FASRS
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Designing Efficient Clinic Workflows for TED Therapy Access
New Methotrexate Protocol in RD Repair in High-Risk PVR Cases
Maria H. Berrocal, MD
Maggie Runner, MD
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
Jessica Randolph, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.